Afamin/Wnt3a Condition Medium

Condition medium to help organoid formation

Wnt signaling is known to be involved in early development, maintenance and regeneration of stem cells, and in cancer formation. Wnt signaling has also been found to play an important role in the growth and maintenance of these processes. In particular, Wnt3a has been revealed to be an essential niche component for maintaining the proliferation of Lgr5-positive stem cells in intestinal epithelial cells and is used for the production of various digestive organoids such as the small intestine, large intestine, stomach, pancreas and liver. Although Wnt3a has been conventionally used for the culture of gut organoids, it is a fat-soluble protein, so it forms aggregates in serum-free medium and can not exert its activity sufficiently. In 2016, Mihara et al. found that high Wnt3a activity can be maintained by forming a complex with Wnt3a by Afamin, which is one of the components of serum. In addition, by using Afamin and Wnt3a complex for organoid culture, long-term culture of organoid becomes possible. This new medium will result in optimal success for your organoid experiments.

Mechanism of Wnt3a Stabilization by Afamin Proteins

Afamin/Wnt3a CM increased Lgr5 Positive Stem Cells Expressed td Tomato

This data obtained from collaboration with Dr. Sato, Keio Univ

Images on the top panels show a bright field of human color organoids. Images on the bottom panels show fluorescent LGR5 positive stem cells that express td tomato regulated by Lgr5 promoter. Afamin/Wnt3a CM maintained LGR5 positive stem cell growth is seen at greater levels compared with cell growth in commercial recombinant Wnt3a (300ng/mL).

Product Highlights

Product CodeProduct Name
J2-001Afamin/Wnt3a CM
J2-002Recombinant Afamin/Wnt3a


  1. Ikezawa, K., Ekawa, T., Hasegawa, S., Kai, Y., Takada, R., Yamai, T., Fukutake, N., Ogawa, H., Akazawa, T., Mizote, Y., Tatsumi, K., Nagata, S., Asukai, K., Takahashi, H., Ohkawa, K., & Tahara, H. (2022). Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle aspiration in patients with pancreatic cancer. Endoscopy International Open, 10(01).
  2. Kim, D., Yoon, Y.-J., Choi, D., Kim, J., & Lim, J.-Y. (2021). 3D organoid culture from adult salivary gland tissues as an ex vivo modeling of salivary gland morphogenesis. Frontiers in Cell and Developmental Biology, 9.
  3. Genshaft, A. S., Ziegler, C. G., Tzouanas, C. N., Mead, B. E., Jaeger, A. M., Navia, A. W., King, R. P., Mana, M. D., Huang, S., Mitsialis, V., Snapper, S. B., Yilmaz, Ö. H., Jacks, T., Van Humbeck, J. F., & Shalek, A. K. (2021). Live cell tagging tracking and isolation for spatial transcriptomics using photoactivatable cell dyes. Nature Communications, 12(1).
  4. Wang, Z., Guo, Y., Jin, Y., Zhang, X., Geng, H., Xie, G., Ye, D., Yu, Y., Liu, D., Zhou, D., Li, B., Luo, Y., Peng, S., & Li, J. (2021). Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids. Cancer Cell International, 21(1).
  5. Wang, Z., Jin, Y., Guo, Y., Tan, Z., Zhang, X., Ye, D., Yu, Y., Peng, S., Zheng, L., & Li, J. (2021). Conversion therapy of intrahepatic cholangiocarcinoma is associated with improved prognosis and verified by a case of patient-derived organoid. Cancers, 13(5), 1179.
  6. Wang, Z., Jin, Y., Guo, Y., Tan, Z., Zhang, X., Ye, D., Yu, Y., Peng, S., Zheng, L., & Li, J. (2021). Conversion therapy of intrahepatic cholangiocarcinoma is associated with improved prognosis and verified by a case of patient-derived organoid. Cancers, 13(5), 1179.
  7. Mae, S.-I., Ryosaka, M., Sakamoto, S., Matsuse, K., Nozaki, A., Igami, M., Kabai, R., Watanabe, A., & Osafune, K. (2020). Expansion of human IPSC-derived ureteric bud organoids with repeated branching potential. Cell Reports, 32(4), 107963.
  8. K. Miyabayashi, et al., Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes. ,Cancer Discov. 10 (2020)[PMID: 32703770]
  9. Y. Nanki, et al., Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing. ,Scientific Reports 28 (2020) [PMID: 32724113]
  10. S. Mae, et al., Expansion of Human iPSC-Derived Ureteric Bud Organoids with Repeated Branching Potential. ,Cell Reports 32 (2020)[PMID: 32726627]
  11. N. Sasaki, et al., Development of a Scalable Coculture System for Gut Anaerobes and Human Colon Epithelium. , Gastroenterology 159 (2020) [PMID: 32199883]
  12. K. Nanki, et al., Somatic inflammatory gene mutations in human ulcerative colitis epithelium., Nature 577 (2020) [PMID: 31853059]
  13. S. Sugimoto, et al., Organoid Derivation and Orthotopic Xenotransplantation for Studying Human Intestinal Stem Cell Dynamics., Methods Mol Biol. 2171 (2020) [PMID: 32705652]
  14. K. Nanki, et al., Divergent routes toward Wnt and R-spondin niche independency during human gastric carcinogenesis., Cell 174 (2018) [PMID: 30096312]
  15. S. Sugimoto, et al., Reconstruction of the human colon epithelium in vivo., Cell Stem Cell 22 (2018) [PMID: 29290616]
  16. T. Seino, et al., Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression., Cell Stem Cell 22 (2018) [PMID: 29337182]
  17. E. Mihara, et al., Active and water-soluble form of lipidated Wnt protein is maintained by a serum glycoprotein afamin/α-albumin., eLife 5 (2016) [PMID: 26902720]